AICAR attenuates postoperative abdominal adhesion formation by inhibiting oxidative stress and promoting mesothelial cell repair

• Published in: PloS one 2022-09, Vol.17 (9), p.e0272928-e0272928
• Main Authors: Wu, Yunhua, Duan, Xianglong, Gao, Zengzhan, Yang, Ni, Xue, Fei
• Format: Article
• Language: English
• Subjects: Abdomen; Abrasion; Abrasion resistance; Actin; Adenosine; Adenosine monophosphate; Adhesion; AMP; Autophagy; Biology and Life Sciences; Catalase; Cecum; Complications; Cytokeratin; E-cadherin; Fibrosis; Gene expression; Glutathione; Glutathione peroxidase; Growth factors; Health aspects; Inflammation; Injury prevention; Kinases; Medicine and Health Sciences; Mitochondria; Muscles; Nitric oxide; Oxidative stress; Oxygen; Peritoneum; Peroxidase; Picric acid; Protein kinase; Protein kinases; Reactive oxygen species; Repair; Research and Analysis Methods; Smooth muscle; Sodium; Sodium hyaluronate; Staining; Superoxide dismutase; Surgery; Thickness; Transforming growth factor-b1; Vimentin
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0272928

Postoperative abdominal adhesion is one of most common complications after abdominal operations. 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) is an adenosine 5'-monophosphate activated protein kinase (AMPK) pathway agonist that inhibits inflammation, reduces cell fibrosis and cellular reactive oxygen species (ROS) injury, promotes autophagy and mitochondrial function. This study aimed to explore the mechanism of AICAR in inhibiting adhesion formation. Forty rats were randomly divided into five groups. All of the rats except the sham group received cecal abrasion to establish an adhesion model. The rats in the sodium hyaluronate group were treated with 2 mL sodium hyaluronate before closing the peritoneal cavity. The AICAR 1 and 2 groups were treated with 100 mg/kg and 200 mg/kg AICAR, respectively. Seven days after the operation, all of the rats were euthanized, and the adhesion condition was evaluated by Nair's system. Inflammation was assessed by Eosin-hematoxylin (HE) staining and transforming growth factor-[beta] (TGF-[beta]1) detection. Oxidative stress effect was determined by ROS, nitric oxide (NO) level, superoxide dismutase (SOD), catalase, glutathione peroxidase (Gpx) and malondialdehyde (MDA) levels in adhesion tissue. Then, Sirius red picric acid staining was used to detect the fiber thickness. Immunohistochemical staining of cytokeratin-19 (CK-19), alpha-smooth muscle actin ([alpha]-SMA) and nuclear factor erythroid 2-related factor 2 (Nrf2) was also performed. Finally, HMrSV5 cells were treated with TGF-[beta]1 and AICAR, the mRNA expression of E-cadherin, [alpha]-SMA and vimentin was assessed by q-PCR and cellular immunofluorescent staining. The rats in the AICAR-treated group had fewer adhesion formation incidences and a reduced Nair's score. The inflammation was determined by HE staining and TGF-[beta]1 concentration. The ROS, SOD, Catalase, Gpx, MDA levels and fiber thickness were decreased by AICAR treatments compared to the control. However, the NO production, Nrf2 levels and peritoneal mesothelial cell integrity were promoted after AICAR treatments. In vitro work, AICAR treatments reduced E-cadherin, [alpha]-SMA and vimentin mRNA level compared to that in the TGF-[beta]1 group. AICAR can inhibit postoperative adhesion formation by reducing inflammation, decreasing oxidative stress response and promoting peritoneal mesothelial cell repair.